This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, D. Articles by Roberts, R. Search for Related Content PubMed PubMed Citation Articles by Li, D. Articles by Roberts, R. Pubmed/NCBI databases Gene GEO Profiles HomoloGene OMIM Protein UniGene Medline Plus Health Information Cardiomyopathy Related Collections Clinical genetics Myocardial cardiomyopathy disease Heart failure - basic studies

(Circulation. 2001;104:2188.)
© 2001 American Heart Association, Inc.

Clinical Investigation and Reports

Novel Cardiac Troponin T Mutation as a Cause of Familial Dilated Cardiomyopathy

Duanxiang Li, MD; Grazyna Z. Czernuszewicz, MS; Oscar Gonzalez, BS; Terry Tapscott, BS; Akihiko Karibe, MD, PhD; Jean-Bernard Durand, MD; Ramon Brugada, MD; Rita Hill, RN; Jane M. Gregoritch, MD; Jeffrey L. Anderson, MD; Miguel Quiñones, MD; Linda L. Bachinski, PhD; Robert Roberts, MD

From the Section of Cardiology, Baylor College of Medicine (D.L., G.Z.C., O.G., T.T., A.K., R.B., R.H., M.Q., L.L.B., R.R.), and M.D. Anderson Cancer Center (J.-B.D.), Houston, Tex; Kaiser Permanente Hospital, Los Angeles, Calif (J.M.G.); and the University of Utah, Salt Lake City (J.L.A.).

Correspondence to Robert Roberts, MD, Don W. Chapman Professor of Medicine, Professor of Medicine and Cell Biology, Department of Medicine, Section of Cardiology, 6550 Fannin, MS SM677, Baylor College of Medicine, Houston, TX 77030. E-mail rrobertsr{at}bcm.tmc.edu

Background— Familial dilated cardiomyopathy (FDCM) and hypertrophic cardiomyopathy (FHCM) are the 2 most common forms of primary cardiac muscle diseases. Studies indicate that mutations in sarcomeric proteins are responsible for FHCM and suggest that mutations in cytoskeletal proteins cause FDCM. Evidence is evolving, however, that such conclusions are premature.

Methods and Results— A novel missense mutation in the cardiac troponin T gene was identified by direct sequencing and confirmed by endonuclease restriction analysis in a large family with FDCM that we had previously mapped to chromosome 1q32. The mutation substitutes tryptophan for a highly conserved amino acid, arginine, at amino acid residue 141 (Arg141Trp). The mutation occurs within the tropomyosin-binding domain of cardiac troponin T and alters the charge of the residue. This mutation cosegregates with the disease, being present in all 14 living affected individuals. The mutation was not found in 100 normal control subjects. Clinical features were congestive heart failure with premature deaths. The age of onset and severity of the disease are highly variable, with incomplete penetrance. Because 15 mutations in troponin T are known to cause FHCM, 219 probands with FHCM were screened, and none had the mutation.

Conclusions— Thus, the novel cardiac troponin T mutation Arg141Trp is responsible for FDCM in our family. Because several mutations in troponin T have already been recognized to be responsible for FHCM, it appears that the phenotype, whether it be hypertrophy or dilatation, is determined by the specific mutation rather than the gene.

Key Words: cardiomyopathy • genetics • molecular biology

This article has been cited by other articles:

				R. Lombardi, A. Bell, V. Senthil, J. Sidhu, M. Noseda, R. Roberts, and A. J. Marian Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies Cardiovasc Res, July 1, 2008; 79(1): 109 - 117. [Abstract] [Full Text] [PDF]

				L. Zhang, A. Hu, H. Yuan, L. Cui, G. Miao, X. Yang, L. Wang, J. Liu, X. Liu, S. Wang, et al. A Missense Mutation in the CHRM2 Gene Is Associated With Familial Dilated Cardiomyopathy Circ. Res., June 6, 2008; 102(11): 1426 - 1432. [Abstract] [Full Text] [PDF]

				S. Morimoto Sarcomeric proteins and inherited cardiomyopathies Cardiovasc Res, March 1, 2008; 77(4): 659 - 666. [Abstract] [Full Text] [PDF]

				P. Robinson, P. J. Griffiths, H. Watkins, and C. S. Redwood Dilated and Hypertrophic Cardiomyopathy Mutations in Troponin and {alpha}-Tropomyosin Have Opposing Effects on the Calcium Affinity of Cardiac Thin Filaments Circ. Res., December 7, 2007; 101(12): 1266 - 1273. [Abstract] [Full Text] [PDF]

				E. P. Debold, J. P. Schmitt, J. B. Patlak, S. E. Beck, J. R. Moore, J. G. Seidman, C. Seidman, and D. M. Warshaw Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse {alpha}-cardiac myosin in the laser trap assay Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H284 - H291. [Abstract] [Full Text] [PDF]

				M. Mirza, S. Marston, R. Willott, C. Ashley, J. Mogensen, W. McKenna, P. Robinson, C. Redwood, and H. Watkins Dilated Cardiomyopathy Mutations in Three Thin Filament Regulatory Proteins Result in a Common Functional Phenotype J. Biol. Chem., August 5, 2005; 280(31): 28498 - 28506. [Abstract] [Full Text] [PDF]

				N. G. Mahon, R. T. Murphy, C. A. MacRae, A. L.P. Caforio, P. M. Elliott, and W. J. McKenna Echocardiographic Evaluation in Asymptomatic Relatives of Patients with Dilated Cardiomyopathy Reveals Preclinical Disease Ann Intern Med, July 19, 2005; 143(2): 108 - 115. [Abstract] [Full Text] [PDF]

				G. Venkatraman, A. V. Gomes, W. G. L. Kerrick, and J. D. Potter Characterization of Troponin T Dilated Cardiomyopathy Mutations in the Fetal Troponin Isoform J. Biol. Chem., May 6, 2005; 280(18): 17584 - 17592. [Abstract] [Full Text] [PDF]

				E. L. Burkett and R. E. Hershberger Clinical and genetic issues in familial dilated cardiomyopathy J. Am. Coll. Cardiol., April 5, 2005; 45(7): 969 - 981. [Abstract] [Full Text] [PDF]

				E. Villard, L. Duboscq-Bidot, P. Charron, A. Benaiche, V. Conraads, N. Sylvius, and M. Komajda Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene Eur. Heart J., April 2, 2005; 26(8): 794 - 803. [Abstract] [Full Text] [PDF]

				J. Mogensen, R. T. Murphy, T. Shaw, A. Bahl, C. Redwood, H. Watkins, M. Burke, P. M. Elliott, and W. J. McKenna Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2033 - 2040. [Abstract] [Full Text] [PDF]

				G. Venkatraman, K. Harada, A. V. Gomes, W. G. L. Kerrick, and J. D. Potter Different Functional Properties of Troponin T Mutants That Cause Dilated Cardiomyopathy J. Biol. Chem., October 24, 2003; 278(43): 41670 - 41676. [Abstract] [Full Text] [PDF]

				P Sebillon, C Bouchier, L D Bidot, G Bonne, K Ahamed, P Charron, V Drouin-Garraud, A Millaire, G Desrumeaux, A Benaiche, et al. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations J. Med. Genet., August 1, 2003; 40(8): 560 - 567. [Abstract] [Full Text] [PDF]

				P. Robinson, M. Mirza, A. Knott, H. Abdulrazzak, R. Willott, S. Marston, H. Watkins, and C. Redwood Alterations in Thin Filament Regulation Induced by a Human Cardiac Troponin T Mutant That Causes Dilated Cardiomyopathy Are Distinct from Those Induced by Troponin T Mutants That Cause Hypertrophic Cardiomyopathy J. Biol. Chem., October 18, 2002; 277(43): 40710 - 40716. [Abstract] [Full Text] [PDF]

				K. A. Crispell, E. L. Hanson, K. Coates, W. Toy, and R. E. Hershberger Periodic rescreening is indicated for family members at risk of developing familial dilated cardiomyopathy J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1503 - 1507. [Abstract] [Full Text] [PDF]